$PMVP PMV Pharmaceuticals, Inc. Insider Trading Week 39/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PMV Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PMV Pharmaceuticals, Inc. in week 39/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 1,768,023 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 760,267 | 0 | 2,528,290 | 1.8 M to 2.5 M (+43.00 %) | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 1,768,023 | 0 | 1,768,023 | 0 to 1.8 M | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Buy | C | 0.00 | 760,267 | 0 | 760,267 | 0 to 760.3 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 132,601 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 751,409 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 2,601,637 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 693,769 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 132,601 | 0 | 132,601 | 0 to 132.6 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 751,409 | 0 | 751,409 | 0 to 751.4 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 2,601,637 | 0 | 2,601,637 | 0 to 2.6 M | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Option Exercise | C | 0.00 | 1,768,023 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 693,769 | 0 | 693,769 | 0 to 693.8 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 760,267 | 0 | 2,528,290 | 1.8 M to 2.5 M (+43.00 %) | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Nextech V Oncology S.C.S., SIC ... | Buy | C | 0.00 | 1,768,023 | 0 | 1,768,023 | 0 to 1.8 M | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Wellington Biomedical Innovati ... | Buy | C | 0.00 | 760,267 | 0 | 760,267 | 0 to 760.3 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 132,601 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 751,409 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 2,601,637 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Option Exercise | C | 0.00 | 693,769 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 132,601 | 0 | 132,601 | 0 to 132.6 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 751,409 | 0 | 751,409 | 0 to 751.4 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 2,601,637 | 0 | 2,601,637 | 0 to 2.6 M | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Euclidean Capital LLC | Buy | C | 0.00 | 693,769 | 0 | 693,769 | 0 to 693.8 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 28,129 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 732,137 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 32,708 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Option Exercise | C | 0.00 | 586,099 | 0 | 0 | ||
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 28,129 | 0 | 60,837 | 32.7 K to 60.8 K (+86.00 %) | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 32,708 | 0 | 32,708 | 0 to 32.7 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 732,137 | 0 | 2,268,236 | 1.5 M to 2.3 M (+47.66 %) | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | C | 0.00 | 586,099 | 0 | 1,536,099 | 950 K to 1.5 M (+61.69 %) | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Boxer Capital, LLC | Buy | P | 18.00 | 950,000 | 17,100,000 | 950,000 | 0 to 950 K | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 114,039 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 380,133 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 518,191 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,076,891 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 4,025,076 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 114,039 | 0 | 114,039 | 0 to 114 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 380,133 | 0 | 6,475,291 | 6.1 M to 6.5 M (+6.24 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 518,191 | 0 | 6,095,158 | 5.6 M to 6.1 M (+9.29 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,076,891 | 0 | 5,576,967 | 4.5 M to 5.6 M (+23.93 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 4,025,076 | 0 | 4,500,076 | 475 K to 4.5 M (+847.38 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORBIMED ADVISORS LLC | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 114,039 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 380,133 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 518,191 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,076,891 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 4,025,076 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 114,039 | 0 | 114,039 | 0 to 114 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 380,133 | 0 | 6,475,291 | 6.1 M to 6.5 M (+6.24 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 518,191 | 0 | 6,095,158 | 5.6 M to 6.1 M (+9.29 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 1,076,891 | 0 | 5,576,967 | 4.5 M to 5.6 M (+23.93 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | C | 0.00 | 4,025,076 | 0 | 4,500,076 | 475 K to 4.5 M (+847.38 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Thompson Peter A. | Director | Buy | P | 18.00 | 475,000 | 8,550,000 | 475,000 | 0 to 475 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Option Exercise | C | 0.00 | 760,267 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Option Exercise | C | 0.00 | 1,768,023 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Buy | C | 0.00 | 760,267 | 0 | 2,528,290 | 1.8 M to 2.5 M (+43.00 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | Schroeder Thilo | Director | Buy | C | 0.00 | 1,768,023 | 0 | 1,768,023 | 0 to 1.8 M |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 265,203 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 1,040,654 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 3,488,398 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Option Exercise | C | 0.00 | 1,620,101 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 265,203 | 0 | 6,469,356 | 6.2 M to 6.5 M (+4.27 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 1,040,654 | 0 | 6,204,153 | 5.2 M to 6.2 M (+20.15 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 3,488,398 | 0 | 5,163,499 | 1.7 M to 5.2 M (+208.25 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | C | 0.00 | 1,620,101 | 0 | 1,675,101 | 55 K to 1.7 M (+2,945.64 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | P | 18.00 | 55,000 | 990,000 | 55,000 | 0 to 55 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 265,203 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 1,040,654 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 3,488,398 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 1,620,101 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 265,203 | 0 | 6,469,356 | 6.2 M to 6.5 M (+4.27 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 1,040,654 | 0 | 6,204,153 | 5.2 M to 6.2 M (+20.15 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 3,488,398 | 0 | 5,163,499 | 1.7 M to 5.2 M (+208.25 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 1,620,101 | 0 | 1,675,101 | 55 K to 1.7 M (+2,945.64 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | ORONSKY ARNOLD L | Director | Buy | P | 18.00 | 55,000 | 990,000 | 55,000 | 0 to 55 K |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 760,265 | 0 | 0 | |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 18.00 | 950,000 | 17,100,000 | 1,710,265 | 760.3 K to 1.7 M (+124.96 %) |
| Sep 29 2020 | PMVP | PMV Pharmaceutical ... | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 760,265 | 0 | 760,265 | 0 to 760.3 K |